(Nasdaq: BCTX) (TSX: BCT) BriaCell teams up with New York Cancer & Blood Specialists for Phase 3 study of Bria-IMT™ in advanced breast cancer. Together, pioneering new paths in cancer care at one of the nation’s leading cancer centers.

https://globenewswire.com/news-release/2023/1...ancer.html

#Phase3Study #CancerCare